Abstract
Non-coding RNAs, especially microRNAs (miRNAs), have been recently found to play a major role in the post-transcriptional regulation of both development and dysfunction of the cardiovascular system. Mechanistically, the induction or repression of miRNAs occurring in cardiovascular dysfunction triggers downstream cardiac events in a celltype- specific manner. More importantly, the endogenous microRNAs’ disturbance can be modified to rescue cardiac function through exogenous overexpressing or neutralizing strategy. In this paper, we summarizes the current knowledge about miRNAs functions as well as their role in cardiac development and disease, and reports novel miRNAs-based therapeutic approaches to counteract maladaptive remodeling upon cardiac dysfunction.
Keywords: Cardiovascular, development, dysfunction, miRNA.
Current Medicinal Chemistry
Title:Roles of miRNA in Cardiovascular Development and Dysfunction
Volume: 20 Issue: 29
Author(s): W. Huang, Q. Yu, Q. Wang and F. Cao
Affiliation:
Keywords: Cardiovascular, development, dysfunction, miRNA.
Abstract: Non-coding RNAs, especially microRNAs (miRNAs), have been recently found to play a major role in the post-transcriptional regulation of both development and dysfunction of the cardiovascular system. Mechanistically, the induction or repression of miRNAs occurring in cardiovascular dysfunction triggers downstream cardiac events in a celltype- specific manner. More importantly, the endogenous microRNAs’ disturbance can be modified to rescue cardiac function through exogenous overexpressing or neutralizing strategy. In this paper, we summarizes the current knowledge about miRNAs functions as well as their role in cardiac development and disease, and reports novel miRNAs-based therapeutic approaches to counteract maladaptive remodeling upon cardiac dysfunction.
Export Options
About this article
Cite this article as:
Huang W., Yu Q., Wang Q. and Cao F., Roles of miRNA in Cardiovascular Development and Dysfunction, Current Medicinal Chemistry 2013; 20 (29) . https://dx.doi.org/10.2174/0929867311320290007
DOI https://dx.doi.org/10.2174/0929867311320290007 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance
Current Cardiology Reviews Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management
Current Vascular Pharmacology The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential
Current Medicinal Chemistry Developments in Imaging Technologies Related to Hypertensive Cardiovascular Diseases
Current Pharmaceutical Design Non Invasive Imaging of Myocardial Infarction with Computed Tomography and Magnetic Resonance
Current Vascular Pharmacology Current Advances in the Synthesis and Antitumoral Activity of SIRT1-2 Inhibitors by Modulation of p53 and Pro-Apoptotic Proteins
Current Medicinal Chemistry Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Highlighting Exosomes’ Function in Cardiovascular Diseases
Current Cardiology Reviews Lipoprotein Subfractions, Uric Acid and Cardiovascular Risk in End-Stage Renal Disease (ESRD) Patients
Current Vascular Pharmacology The Diagnostic and Prognostic Value of Brain Natriuretic Peptide and Aminoterminal (nt)-pro Brain Natriuretic Peptide
Current Pharmaceutical Design Type 2 Diabetes and Heart Failure: Challenges and Solutions
Current Cardiology Reviews Pure Polyphenols Applications for Cardiac Health and Disease
Current Pharmaceutical Design Potential New Targets for Antithrombotic Therapy
Current Pharmaceutical Design Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Cardiovascular & Hematological Disorders-Drug Targets Autophagy: For Better or for Worse, in Good Times or in Bad Times …
Current Molecular Medicine Effect of a New Class of Compounds of the Group of Substituted 5R1, 6H2-1,3,4-thiadiazine-2-amines on the Inflammatory and Cytokine Response in Experimental Myocardial Infarction
Current Vascular Pharmacology Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Engineering Three-Dimensional Cardiac Microtissues for Potential Drug Screening Applications
Current Medicinal Chemistry New Developments in Targeted Analysis of Protein Posttranslational Modifications
Current Proteomics Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and Perspectives
Current Clinical Pharmacology